Biotech Foods SL

biotech-foods.com

Our processes are based on tissue growth by in vitro cell culture processes, which are the processes by which cells are grown outside of their natural environment. We regulate their physico-chemical conditions for providing a nice and controlled environment for natural proliferation and healthy tissue growth.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

XYLYX BIO LAUNCHES SPECIALIZED CONTRACT R&D SERVICES THAT SUPPORT IMPROVED ASSESSMENT OF ANTIFIBROTIC DRUG CANDIDATE EFFICACY

Xylyx Bio | September 30, 2020

news image

Xylyx Bio, a leader in advanced disease models for drug discovery, today announced the launch of specialized contract R&D services that support improved assessment of antifibrotic drug candidate efficacy. Despite ongoing advances, the current drug discovery paradigm is highly inefficient. Approximately 40% of development costs are associated with preclinical studies, yet 80% of drug candidates fail before reaching Phase I trials, largely due to lack of translatability of efficacy data to hum...

Read More

KANE BIOTECH WELCOMES RENOWNED CANADIAN VETERINARIAN, DR. JEAN GAUVIN, AS CHIEF VETERINARY OFFICER

BioSpace | February 20, 2020

news image

Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that it has appointed Jean Gauvin, DVM, as its Chief Veterinary Officer (“CVO”), effective immediately. In the newly-created position of CVO, Dr. Gauvin will serve as a liaison between Kane Biotech and industry, guide the K...

Read More

INNATOSS LABORATORIES LAUNCHES NEUTRALIZING ANTIBODY TESTING SERVICE AGAINST SARS-COV-2 USING GENSCRIPT'S CPASS ™ KIT

Innatoss Laboratories | September 15, 2020

news image

Innatoss Laboratories announced today the first neutralizing antibody testing service against SARS-CoV-2 for the public in Europe, using GenScript's cPass ™ SARS-CoV-2 Neutralization Antibody Detection Kit. The kit is the first in the world that enables rapid detection of neutralizing antibodies (NAbs), the specific antibodies present in the serum of COVID-19 patients that are responsible for clearing the viral infection. Innatoss is the first medical lab in Europe to provide a service...

Read More

3 BLUE-CHIP BIOTECH STOCKS HITTING NEW HIGHS

The World News Monitor | April 08, 2020

news image

• 3 Blue-Chip Biotech Stocks Hitting New Highs. A basket of biotech stocks have surged to new highs in recent weeks, lifting the iShares Nasdaq Biotechnology Index Fund ETF (IBB) within 15 points of 2019 resistance.The stock posted an all-time high at $128 in Tuesday’s session, lifting above 2019 resistance at $122. Price action into the second half of 2019 carved a long series of lower highs and lower lows, dropping the stock to a six-year low....

Read More
news image

XYLYX BIO LAUNCHES SPECIALIZED CONTRACT R&D SERVICES THAT SUPPORT IMPROVED ASSESSMENT OF ANTIFIBROTIC DRUG CANDIDATE EFFICACY

Xylyx Bio | September 30, 2020

Xylyx Bio, a leader in advanced disease models for drug discovery, today announced the launch of specialized contract R&D services that support improved assessment of antifibrotic drug candidate efficacy. Despite ongoing advances, the current drug discovery paradigm is highly inefficient. Approximately 40% of development costs are associated with preclinical studies, yet 80% of drug candidates fail before reaching Phase I trials, largely due to lack of translatability of efficacy data to hum...

Read More
news image

KANE BIOTECH WELCOMES RENOWNED CANADIAN VETERINARIAN, DR. JEAN GAUVIN, AS CHIEF VETERINARY OFFICER

BioSpace | February 20, 2020

Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that it has appointed Jean Gauvin, DVM, as its Chief Veterinary Officer (“CVO”), effective immediately. In the newly-created position of CVO, Dr. Gauvin will serve as a liaison between Kane Biotech and industry, guide the K...

Read More
news image

INNATOSS LABORATORIES LAUNCHES NEUTRALIZING ANTIBODY TESTING SERVICE AGAINST SARS-COV-2 USING GENSCRIPT'S CPASS ™ KIT

Innatoss Laboratories | September 15, 2020

Innatoss Laboratories announced today the first neutralizing antibody testing service against SARS-CoV-2 for the public in Europe, using GenScript's cPass ™ SARS-CoV-2 Neutralization Antibody Detection Kit. The kit is the first in the world that enables rapid detection of neutralizing antibodies (NAbs), the specific antibodies present in the serum of COVID-19 patients that are responsible for clearing the viral infection. Innatoss is the first medical lab in Europe to provide a service...

Read More
news image

3 BLUE-CHIP BIOTECH STOCKS HITTING NEW HIGHS

The World News Monitor | April 08, 2020

• 3 Blue-Chip Biotech Stocks Hitting New Highs. A basket of biotech stocks have surged to new highs in recent weeks, lifting the iShares Nasdaq Biotechnology Index Fund ETF (IBB) within 15 points of 2019 resistance.The stock posted an all-time high at $128 in Tuesday’s session, lifting above 2019 resistance at $122. Price action into the second half of 2019 carved a long series of lower highs and lower lows, dropping the stock to a six-year low....

Read More